Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
Summary
Science Corporation has successfully placed its vision-restoring microchip into its first patient with Stargardt disease. The company's leader discussed this milestone at a recent technology event, explaining how the project fits into broader efforts to develop advanced brain-computer interfaces.
Max Hodak, the former president and co-founder of Neuralink, detailed on stage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
Source: Read the full story at TechCrunch
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.